Caris Life Sciences announced the promotion of Jonathan Knowles as its new chief scientific officer. Previously Caris' vice chairman, Knowles will retain the responsibilities of that role and assume new ones in taking on the position of chief scientific officer.
In this newly created role, Knowles will oversee the development and commercialization of the company's Carisome platform in cancer testing. Additionally, Knowles will be responsible for globalizing Caris' overall scientific and research capabilities.
Before joining Caris, Knowles was president of group research at Roche and the first chairman of the Board for the Innovative Medicines Initiative, a public-private partnership between the European Commission and 28 pharmaceutical companies focused on disease areas of unmet medical need.
Additionally, Knowles has been awarded a distinguished professorship in personalized healthcare at the Finnish Institute for Molecular Medicine at the University of Helsinki, and has been appointed a visiting chair at the University of Oxford.